IDEAYA: Potential First-in-Class PARG Inhibitor IDE161 Gets FDA Fast Track Designation
IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced …
IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced …
On a quiet day of trading announcements, investors might focus …
Tata Steel UK is reformatting its operations in Port Talbot …
In a major development Monday, Ukrainian President Volodymyr Zelensky has …
In a historic achievement for NASA, the first sample of …
Early signs from the U.S. Futures Index suggest that Wall …
‘As long as economic growth remains steady, creating jobs and …
Irregular rainfall and a pick-up in commodity costs are expected …
The war in Ukraine has been headlining the news as …
Thus far in calendar year 2023 (CY23) the Nifty Midcap …
There are a growing number of companies on the market …
Fox, which just announced that Rupert Murdoch is stepping down …